Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Separating Symptomatic Alzheimer's Disease from Depression based on Structural MRI.

Stefan Klöppel1,2,3,4, Maria Kotschi1,2,3, Jessica Peter4

  • 1Center of Geriatrics and Gerontology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Journal of Alzheimer'S Disease : JAD
|April 5, 2018
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visual Cortical Plasticity Depends on Stimulus Structure and Temporal Dynamics.

NeuroImage·2026
Same author

Human Ventral Tegmental Local Field Potentials in Treatment-Resistant Depression and Obsessive-Compulsive Disorder.

Biological psychiatry·2026
Same author

Cross-trial prediction of treatment response to transcranial direct current stimulation in patients with major depressive disorder.

Progress in neuro-psychopharmacology & biological psychiatry·2025
Same author

The NMDA receptor subunit GluN2D is a potential target for rapid antidepressant action.

Nature communications·2025
Same author

Development of VEP-based biomarkers to assess plasticity states.

Translational psychiatry·2025
Same author

Sex differences in attentional visual processing but not in plasticity-related modulation of visually evoked potentials.

Biological psychology·2025

An automated algorithm shows promise in differentiating Alzheimer's disease (AD) from depression using MRI scans. While not a replacement for clinicians, this AI tool can aid in distinguishing these conditions in older adults.

Area of Science:

  • Neurology
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Older adults with cognitive impairment often present with overlapping symptoms, complicating differential diagnosis between Alzheimer's disease (AD) and depression.
  • Accurate differentiation is crucial as pathology, therapy, and prognosis vary significantly between these conditions.

Purpose of the Study:

  • To evaluate an automated algorithm's ability to distinguish between Alzheimer's disease (AD) and depression in elderly patients using structural MRI data.
  • To assess the algorithm's potential to assist in the differential diagnosis of cognitive impairment.

Main Methods:

  • Utilized T1-weighted structural magnetic resonance imaging (MRI) from 65 elderly individuals (28 with AD, 37 with depression).
  • Employed a pattern recognition algorithm, including leave-one-out cross-validation, to analyze grey matter distribution.
Keywords:
Alzheimer’s diseasedepressionmagnetic resonance imagingsupervised machine learningsupport vector machine

Related Experiment Videos

  • Tested the algorithm in a more complex scenario with five diagnostic categories (AD, frontotemporal dementia, Lewy body dementia, depression, healthy aging).

    • Main Results:

    • The algorithm achieved an area under the ROC curve of up to 0.83 and a balanced accuracy of 0.79 in separating depression from AD.
    • Identified consistent structural differences, demonstrating potential for differential diagnosis.
    • While insufficient for direct multi-class classification, the algorithm's continuous output showed differences between the studied groups.

    Conclusions:

    • Automated analysis of structural MRI shows potential to aid in the differential diagnosis of Alzheimer's disease and depression.
    • The developed algorithm can complement clinical assessments but does not replace them.
    • Further research may refine AI tools for more accurate diagnostic support in cognitive impairment.